Article R4135-16
Any member of a regional council, governed by Titles I to IV of the general civil service regulations must, when he wishes to benefit from the training leave provided for in article L. 4135-11, submit…
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 1141–1150 of 69211 articles for “Art. s. L 237-2 · L 237-15 · L 237-16 · R 237-1”
Any member of a regional council, governed by Titles I to IV of the general civil service regulations must, when he wishes to benefit from the training leave provided for in article L. 4135-11, submit…
I.-The administrative social committee exercises the powers provided for: 1° In articles 47 to 52 and the third paragraph of article 54 of the aforementioned decree of 20 November 2020; 2° In articles…
The application for approval is submitted to the prefecture against receipt. It is forwarded by the prefect to the minister responsible for local authorities who, before making a decision, must submit…
The Chairman of the Conciliation Conference carries out a preliminary examination of the request for conciliation. The Chairman immediately notifies the parties, in a reasoned decision, that the reque…
As part of the pharmacovigilance system, any company or organisation exploiting a medicinal product or a product mentioned in Article R. 5121-150 : 1° Implements a risk management system for each medi…
Any company or organisation exploiting a medicinal product or a product mentioned in Article R. 5121-150 shall implement a pharmacovigilance system in order to fulfil its pharmacovigilance obligations…
Any company or organisation exploiting a medicinal product or a product mentioned in Article R. 5121-150 is required to: 1° Record all adverse reactions suspected of being due to a medicinal product o…
Any company or organisation exploiting a medicinal product or a product referred to in Article R. 5121-150 has at its disposal on a permanent basis the services of a person responsible for pharmacovig…
The company or organisation exploiting a medicinal product or a product referred to in Article R. 5121-150 may not communicate information relating to pharmacovigilance to the general public about thi…
I.-Any company or organisation exploiting a medicinal product or a product mentioned in article R. 5121-150 is required to transmit electronically to the European Medicines Agency a periodic safety up…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More